Los puntos clave no están disponibles para este artículo en este momento.
-induced synaptic deficits, Aβ accumulation, BACE-1 expression and tau hyperphosphorylation. This magnetic drug delivery approach can be extended to preclinical and clinical use and may advance the chances of success in the treatment of neurological disorders like AD in the future.
Amin et al. (Sun,) studied this question.